Mobile Menu Button

University of Cincinnati Medical Center is pleased to share with you Cardiovascular Insights, an educational resource with information on the cutting-edge research, clinical trials, training and innovative treatments that are advancing the field.

    • 27 FEB 17

    A Genetic Variant Can Predispose South Asians to Hypertrophic Cardiomyopathy

    A genetic variant of myosin binding protein C, cardiac (MYBPC3), can predispose South Asians to hypertrophic cardiomyopathy (HCM), but early screening could lower its incidence. Sakthivel Sadayappan, PhD, MBA, professor, division of cardiovascular health and disease and director of the heart branch of Heart, Lung and Vascular Institute, University of Cincinnati Medical Center (UC Medical

    Read more →
    • 27 FEB 17

    Working to Change the Leading Cause of Death Throughout the World

    Every year, approximately 10 million people worldwide, including 600,000 Americans, suffer from venous thromboembolism (VTE),1 and at least one in 12 middle-aged American adults will develop VTE in their remaining lifetime,2 says Richard C. Becker, MD. These statistics are part of the impetus for a national awareness effort—World Thrombosis Day (WTD), which is designed to

    Read more →
    • 27 FEB 17

    Facial Muscle Cells May Help Repair Damage from Cardiovascular Disease

    Researchers at the University of Cincinnati Medical Center (UC Medical Center) are investigating the use of facial muscle-derived progenitor cells – masseter muscle cells – to regenerate cardiomyocytes damaged by cardiovascular disease. Current therapies, such as medications, bypass surgery and donor hearts do not repair or replace cardiomyocytes and come with additional risks such as

    Read more →
    • 21 FEB 17

    EKOS Offers Great Benefits for High-Risk Pulmonary Embolism Patients

    The EkoSonic Pulmonary Embolism (EKOS®) System is “so effective, even for the most complex cases, that it’s hard not to use it for all patients with pulmonary embolism [PE],” says Timothy Smith, MD. Dr. Smith, an interventional cardiologist, is director of the cardiovascular ICU and assistant professor of medicine at the University of Cincinnati Medical

    Read more →
    • 28 OCT 16
    Developments in Arrhythmia Treatment: Reduced Procedure Time, Planning for Telemedicine

    Developments in Arrhythmia Treatment: Reduced Procedure Time, Planning for Telemedicine

    The Arrhythmia Center at the University of Cincinnati (UC) Medical Center, undergoing significant upgrades, is unique in its nationally and internationally recognized electrophysiology group which encompasses strong clinical performance, education and research. Alexandru Costea, MD, professor of medicine, director of the Center for Electrophysiology, Rhythm Disorders and Electro-mechanical Interventions, is leading this multi-faceted cardiac program.

    Read more →
    • 28 OCT 16

    Investigation of a Novel Mediator of Cardiac Hypertrophy Funded by $1.7 Million Grant

    Determining how the protein human antigen R (HuR) is activated, its function after activation, and possible association with cardiac hypertrophy are the goals of a study funded by a $1.7 million National Institute of Health (NIH) five-year grant recently awarded to Michael Tranter, PhD, and principal investigator for the study. Initial findings show that the

    Read more →